Zobrazeno 1 - 10
of 12
pro vyhledávání: '"G J, Locker"'
Autor:
T. Staudinger, G. J. Locker
Publikováno v:
Wiener Medizinische Wochenschrift. 152:564-567
The general approach regarding the treatment of sepsis in patients with oncological or haematological malignancies does not differ significantly from that in immunocompetent individuals, however, there are several specialities. The main causes of sev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad187283a566160fa5f8bc35cbd7354e
https://doi.org/10.1046/j.1563-258x.2002.02101.x
https://doi.org/10.1046/j.1563-258x.2002.02101.x
Autor:
D, Krizanac, A, Bojic, W, Rabitsch, P, Schellongowski, G J, Locker, K, Laczika, T, Staudinger
Publikováno v:
Medizinische Klinik, Intensivmedizin und Notfallmedizin. 109(3)
A patient suffering from severe cutaneous graft versus host disease (GvHD) developed generalized epidermolysis and refractory hypothermia. Due to the insufficient effect of traditional rewarming methods, an endovascular temperature catheter was place
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f513bf01ab2328449b5c326fb7416f43
https://pubmed.ncbi.nlm.nih.gov/24615144
https://pubmed.ncbi.nlm.nih.gov/24615144
Autor:
G J, Locker, T, Staudinger
Publikováno v:
Wiener medizinische Wochenschrift (1946). 152(21-22)
The general approach regarding the treatment of sepsis in patients with oncological or haematological malignancies does not differ significantly from that in immunocompetent individuals, however, there are several specialities. The main causes of sev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6e1ad116b56a07516b51dedec06b8ad3
https://pubmed.ncbi.nlm.nih.gov/12506680
https://pubmed.ncbi.nlm.nih.gov/12506680
Autor:
M, Schmidinger, G, Steger, C, Wenzel, G J, Locker, A C, Budinsky, T, Brodowicz, G, Kramer, M, Marberger, C C, Zielinski
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 24(3)
Various cytokine combinations have been tested for efficacy in the treatment of metastatic renal cell carcinoma (MRCC). Because several immunologic synergisms between granulocyte-macrophage colony-stimulating-factor (GM-CSF) and interleukin-2 (IL-2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::26cddb1d5efe03345708066250a63c0e
https://pubmed.ncbi.nlm.nih.gov/11394504
https://pubmed.ncbi.nlm.nih.gov/11394504
Autor:
M, Schmidinger, A C, Budinsky, C, Wenzel, M, Piribauer, R, Brix, M, Kautzky, W, Oder, G J, Locker, C C, Zielinski, G G, Steger
Publikováno v:
Wiener klinische Wochenschrift. 112(14)
Glutathione has been shown to be an effective chemoprotector against cisplatin-induced side effects in patients with ovarian cancer. In view of this fact, we performed a randomized clinical pilot-trial in the management of other solid tumors in order
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b2d12e82c07b84b17be70f360cf351dd
https://pubmed.ncbi.nlm.nih.gov/11008323
https://pubmed.ncbi.nlm.nih.gov/11008323
Autor:
M, Schmidinger, G G, Steger, C, Wenzel, G J, Locker, T, Brodowicz, A C, Budinsky, C, Wiltschke, G, Kramer, M, Marberger, C C, Zielinski
Publikováno v:
Cancer immunology, immunotherapy : CII. 49(7)
Because of the known efficacy of several cytokines in the treatment of advanced renal cell cancer (RCC), we have conducted a phase II trial of the efficacy and toxicity of subcutaneous interferon gamma (IFNgamma) and interleukin-2 (IL-2).63 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::292d8fdf5fbf725330502bd48ff512a6
https://pubmed.ncbi.nlm.nih.gov/10999466
https://pubmed.ncbi.nlm.nih.gov/10999466
Autor:
G J, Locker, S, Kapiotis, M, Veitl, R M, Mader, B, Stoiser, J, Kofler, A E, Sieder, H, Rainer, G G, Steger, C, Mannhalter, O F, Wagner
Publikováno v:
British journal of haematology. 105(4)
Treatment with intravenous recombinant human interleukin-2 (rh IL-2) is frequently accompanied by the capillary leak syndrome and disturbances of the coagulation system. Although the exact mechanisms are still not fully understood, the involvement of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b76962e7aaa74cacba6d8b4a9e88443d
https://pubmed.ncbi.nlm.nih.gov/10554800
https://pubmed.ncbi.nlm.nih.gov/10554800
Publikováno v:
VASA. Zeitschrift fur Gefasskrankheiten. 28(1)
This case report describes a patient with persistent left superior vena cava (LSVC) as discovered by difficult placement of a pulmonary artery catheter via the left subclavian vein. After positioning in wedge position, chest x-ray showed a catheter r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f25b0a9e9d4ba85a4cff89595dacccc9
https://pubmed.ncbi.nlm.nih.gov/10191709
https://pubmed.ncbi.nlm.nih.gov/10191709
Autor:
B, Stoiser, S, Knapp, F, Thalhammer, G J, Locker, J, Kofler, U, Hollenstein, T, Staudinger, A, Wilfing, M, Frass, H, Burgmann
Publikováno v:
European journal of clinical investigation. 28(8)
The systemic inflammatory response syndrome (SIRS) is viewed as a system-wide inflammatory response. Up until now, no parameter has been available for predicting the development of septic shock. In the present study, we evaluated the usefulness of se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8873329e823eb0bb492c40e42677dc23
https://pubmed.ncbi.nlm.nih.gov/9767363
https://pubmed.ncbi.nlm.nih.gov/9767363
Publikováno v:
Anesthesiology. 86(5)
The esophageal-tracheal Combitube (Kendall-Sheridan Catheter Corp., Argyle, NY) is an effective device for providing adequate gas exchange. However, tracheal suctioning is impossible with the Combitube placed in the esophageal position. To eliminate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4cd7d4eb026464d128cf1044bcb2929c
https://pubmed.ncbi.nlm.nih.gov/9158352
https://pubmed.ncbi.nlm.nih.gov/9158352